PLRX compared with PMVP: revenue, margins and what each company keeps, and the suppliers and customers both name

PLRXPliant Therapeutics, Inc.

Mkt capRevenueRevenue

PMVPPMV Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

PLRXPliant Therapeutics, Inc.

PMVPPMV Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Earnings history

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

last 4 reports each · paired by recencyMethod ›

PLRX1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±55.4%▲+3.88%×0.07

PMVP1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+3.70%—

= impliedPLRX realized, solidPMVP realized, hatchedOne scale, both sides: full bar = 56%× = |realized| ÷ impliedSource: market data

PLRXPliant Therapeutics, Inc.

0.85▼−1.46%· post 0.85

Mkt cap$53.2MRevenue$248,000Q2 FY23

PMVPPMV Pharmaceuticals, Inc.

1.37▲+4.72%· post 1.37

ClosedNov 2 '26

Mkt cap$73.2MRevenue—

Compare

ClosedNov 2 '26

PLRXPliant Therapeutics, Inc.

PMVPPMV Pharmaceuticals, Inc.

0.85▼−1.46%post 0.85

Price

1.37▲+4.72%post 1.37

$53.2M

Mkt cap

$73.2M

Q2 FY23$248,000

Revenue

—

PLRX0.85▼−1.46%vsPMVP1.37▲+4.72%ClosedNov 2 '26